Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$2 Mln
P/E Ratio
--
P/B Ratio
1.32
Industry P/E
--
Debt to Equity
0
ROE
-2.8 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-26.33
CFO
$-67.36 Mln
EBITDA
$-71.20 Mln
Net Profit
$-84.38 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
| -44.89 | -6.25 | -30.58 | -99.34 | -91.97 | -82.95 | -- |
|
BSE Sensex
| 5.34 | 9.68 | 8.04 | 13.44 | 15.08 | 21.17 | 11.60 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
| -99.82 | -47.91 | -70.59 | -7.73 | -55.36 | 12.00 | -68.94 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 53.40 | 9,739.38 | -- | -36.37 | |
| 313.74 | 8,645.76 | 22.58 | 56.46 | |
| 25.70 | 9,378.49 | -- | -30.53 | |
| 120.43 | 11,451.33 | 39.09 | 11.64 |
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio... frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Read more
Chairman, President & CEO
Mr. Francois Michelon
Chairman, President & CEO
Mr. Francois Michelon
Headquarters
Ann Arbor, MI
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of ENDRA Life Sciences Inc (NDRA) stood at $ 8 Mln as on 31-Mar-25
The share price of ENDRA Life Sciences Inc (NDRA) is $3.45 (NASDAQ) as of 12-May-2025 16:14 EDT. ENDRA Life Sciences Inc (NDRA) has given a return of -91.97% in the last 3 years.
ENDRA Life Sciences Inc (NDRA) has a market capitalisation of $ 2 Mln as on 09-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of ENDRA Life Sciences Inc (NDRA) is 1.32 times as on 09-May-2025, a 38% discount to its peers’ median range of 2.13 times.
Since, TTM earnings of ENDRA Life Sciences Inc (NDRA) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the ENDRA Life Sciences Inc (NDRA) and enter the required number of quantities and click on buy to purchase the shares of ENDRA Life Sciences Inc (NDRA).
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
The CEO & director of Mr. Francois Michelon. is ENDRA Life Sciences Inc (NDRA), and CFO & Sr. VP is Mr. Francois Michelon.
There is no promoter pledging in ENDRA Life Sciences Inc (NDRA).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,086
|
|
|
1,077
|
|
|
1,006
|
|
|
864
|
| ENDRA Life Sciences Inc. (NDRA) | Ratios |
|---|---|
|
Return on equity(%)
|
-281.09
|
|
Operating margin(%)
|
-5847.9
|
|
Net Margin(%)
|
-6087.55
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of ENDRA Life Sciences Inc (NDRA) was $0 Mln.
$0.19
(
